Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude

NCT04111263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2022-12-23

No results posted yet for this study

Summary

The aim of this randomized, crossover clinical trial is to determine the efficacy of a gut microbiota-targeted nutritional intervention containing a blend of fermentable fibers and polyphenols (FP) for mitigating increases in GI permeability, and decrements in immune function and neuropsychologic performance following rapid ascent to simulated high altitude. Fifteen healthy young adults will participate in each of three study phases that include a 14-day supplementation period in which participants will consume 1 of 2 supplement bars: placebo (PL, will be consumed during 2 phases) and FP supplementation (will be consumed during one phase only). During the final 2-d of each phase, participants will live in a hypobaric chamber under sea level or high altitude conditions.

Conditions

  • Gastrointestinal Injury
  • Acute Mountain Sickness

Interventions

DIETARY_SUPPLEMENT

FP

Fiber and polyphenol blend

DIETARY_SUPPLEMENT

Placebo

Matched placebo

OTHER

High altitude

Simulated high altitude in altitude chamber using hypobaric hypoxia

OTHER

Sea level

Sea level environment in altitude chamber

Sponsors & Collaborators

  • US Army Combat Capabilities Development Command- Soldier Center

    collaborator UNKNOWN
  • Walter Reed Army Institute of Research (WRAIR)

    collaborator FED
  • University of Reading

    collaborator OTHER
  • United States Army Research Institute of Environmental Medicine

    lead FED

Principal Investigators

  • J. Philip Karl, PhD · United States Army Research Institute of Environmental Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-06
Primary Completion
2022-11-05
Completion
2022-11-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111263 on ClinicalTrials.gov